
    
      This is prospective, multi-center, open-labeled, randomized study to investigate adherence of
      administration of once-daily tacrolimus formulation (AdvagrafÂ®) in newly Taiwanese (Chinese)
      liver transplant patients. The procedure of liver transplantation will follow the
      site-specific procedure. Each subject will be randomized on postoperative day 15 (POD15;
      defined Day 14 +/- 1)
    
  